Global Biotechnology & Cancer Therapeutics
Roswell Park Comprehensive Cancer Center is a private, nonprofit NCI-designated Comprehensive Cancer Center in Buffalo, NY providing full-spectrum cancer care, research, and screening to patients across Western New York and beyond, with unique assets including the world's oldest Familial Ovarian Cancer Registry and the EDDY mobile screening fleet.
- Company typePrivate
- Founded1898
- HeadquartersBuffalo, United States
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What Global Biotechnology & Cancer Therapeutics does
Roswell Park Comprehensive Cancer Center, founded in 1898 and headquartered in Buffalo, New York, is a private, nonprofit NCI-designated Comprehensive Cancer Center and the only such designated center in New York State outside of New York City. The institution provides the full spectrum of cancer care — surgery, radiation therapy, chemotherapy, immunotherapy, cellular therapy, HIPEC, theranostics, and clinical trials — across all cancer types and stages, supported by an extensive support services program (psychiatry, palliative care, fertility preservation, survivorship, integrative medicine) and a research infrastructure that includes a Biorepository, Bioinformatics, and a Translational Research program. Patient acquisition is multi-channel: physician referrals through the Partners In Practice network and the RPMD mobile app, direct-to-patient outreach via the MyRoswell portal, community outreach including ~10 community meetings per month, and the EDDY mobile cancer screening fleet (two units launched 2022 and 2025) that has screened nearly 3,000 people across 120 zip codes and 52 locations.
The center's revenue mechanics are a hybrid of pay-as-you-go clinical billing, research grants and clinical-trial funding, philanthropic support (Roswell Park Alliance Foundation, Ride for Roswell — $6.3M raised in 2026), and insurance reimbursements. Specialized programs target distinct segments: young adults (fertility preservation in partnership with Buffalo IVF Associates), Indigenous communities (Department of Indigenous Cancer Health, MOU with Indian Health Service, partnership with Seneca Nation), first responders (~750 Buffalo firefighters scanned through the Buffalo Fire Department program), and at-risk screening populations (breast, cervical, colorectal, lung, and prostate). Core differentiating assets include the Familial Ovarian Cancer Registry — the world's largest and oldest of its kind with 50,000+ participants and 2,700+ families since 1981 — and a five-accreditation stack (NCI Comprehensive Cancer Center, NCCN member, Magnet nursing, Commission on Cancer, Healthcare Equality Index Leader). Distribution extends through the main Buffalo campus, the Williamsville Breast Care of WNY satellite, telehealth, the statewide Roswell Park Care Network, and the mobile EDDY fleet, positioning the institution as both a regional anchor and a nationally networked research entity.
Global Biotechnology & Cancer Therapeutics firmographics
Firmographics- Name
- Global Biotechnology & Cancer Therapeutics
- Legal name
- Roswell Park Comprehensive Cancer Center
- Website
- https://roswellpark.org
- Company type
- Private
- Founded year
- 1898
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Roswell Park Comprehensive Cancer Center is a private, nonprofit NCI-designated Comprehensive Cancer Center in Buffalo, NY providing full-spectrum cancer care, research, and screening to patients across Western New York and beyond, with unique assets including the world's oldest Familial Ovarian Cancer Registry and the EDDY mobile screening fleet.
- Ownership category
- akta.pro rank
Global Biotechnology & Cancer Therapeutics industry classification
Industry- Product category
- Cancer Treatment & Oncology Services
- NAICS
- Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Hospitals (8060), Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
- akta.pro secondary industries
- Gynecologic Oncology (HLAKAFAF), Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE)
Keywords
Where Global Biotechnology & Cancer Therapeutics is headquartered
LocationHeadquarters
- HQ city
- Buffalo
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Global Biotechnology & Cancer Therapeutics business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Patient Care Services: Direct healthcare services including cancer treatment, surgery, radiation, chemotherapy, immunotherapy, diagnostic imaging, laboratory services, and clinical care across all cancer types and stages
- Clinical Trials: Research-based treatments offered through clinical trial participation, potentially generating research funding and grants
- Donations and Fundraising: Philanthropic support through Ride for Roswell event ($6.3 million in 2026), general donations, and foundation support (Roswell Park Alliance Foundation)
- Cancer Screening Services: Screening programs for breast, cervical, colorectal, lung, and prostate cancer including mobile EDDY units
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | Healthcare services pricing is individualized based on treatment needs |
| Other | Pay-as-you-go | Financial assistance programs for uninsured/underinsured patients |
Go-to-market motion3 records
Distribution channels6 records
Marketing channels8 records
Global Biotechnology & Cancer Therapeutics product offering
Product offeringCore offering
Global Biotechnology & Cancer Therapeutics delivers comprehensive cancer care spanning prevention, screening, diagnosis, treatment, and survivorship, including surgery, radiation therapy, chemotherapy, immunotherapy, cellular therapy, and HIPEC. It operates a mobile cancer screening program (EDDY), runs clinical trials, and maintains the world's largest Familial Ovarian Cancer Registry, serving patients and referring physicians across Western New York, New York State, and the broader Northeast U.S.
Product overview
Roswell Park Comprehensive Cancer Center is a healthcare institution offering comprehensive cancer care services rather than a traditional technology product company. The organization's offerings include EDDY (Early Detection Driven to You) - a mobile cancer screening unit, the MyRoswell Patient Portal for patient access, the RPMD physician referral app, immunotherapy treatments, the Department of Indigenous Cancer Health, fertility preservation services, the Familial Ovarian Cancer Registry research program, cancer coaching, the Elevate Salon support service, and the Roswell Park Care Network partnership. These services span cancer screening, treatment, survivorship support, and community outreach across Western New York.
Differentiator
Problem solved
Functional benefit
Brands
- EDDY - Early Detection Driven to You: Mobile cancer screening unit that brings breast, lung, and prostate cancer screening directly to communities across Western New York
- Indigenous & Rural Patient Navigation Program
- Familial Ovarian Cancer Registry
Products and services
- Immunotherapy Program World-leading immune-based treatments and vaccines for cancer patients, offering advanced immunotherapy options for various cancer types.
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Advanced treatment for certain abdominal cancers that delivers heated chemotherapy directly to the affected area during surgery, combining surgical and chemotherapeutic approaches.
- Theranostics Combines diagnostics and therapeutics using targeted radioactive drug therapy to enable precise cancer diagnosis and treatment.
- Transplant & Cellular Therapy Transplant and cellular therapy services for cancer patients, including hematopoietic stem cell transplantation and advanced cellular therapies.
- Radiation Therapy Comprehensive radiation oncology services for cancer patients, offering advanced radiation therapy modalities.
- Surgical Oncology Surgical oncology services for cancer patients, including cancer surgery and plastic & reconstructive surgery.
- Photodynamic Therapy (PDT) Photodynamic therapy for cancer patients, using light-activated drugs to treat targeted tumors.
- Imaging Services (3D Mammography) Diagnostic imaging services including 3D mammography (digital tomosynthesis) for breast cancer screening, improving detection of early cancers especially in women with dense breast tissue and reducing the need for additional imaging.
- Clinical Trials Clinical trial program offering cancer patients access to investigational treatments, novel therapies, and cutting-edge oncology research protocols.
- Genetic Testing & Counseling Genetic testing and counseling services for individuals with family history of cancer, helping identify hereditary cancer risk and inform prevention strategies.
- EDDY - Mobile Cancer Screening Mobile cancer screening program (Early Detection Driven to You) that brings breast, lung, and prostate cancer screening directly to underserved communities across 52+ locations in Western New York, having screened nearly 3,000 people from 120 zip codes.
- Cancer Screening Programs Comprehensive cancer screening programs covering breast, cervical, colorectal, lung, and prostate cancers, including high-risk screening clinics for breast, GYN, lung, and pancreatic cancer.
- Fertility Preservation Program Program helping young adult cancer patients (20s-30s) understand fertility risks posed by diagnosis and treatment, and options for fertility preservation before cancer treatment begins.
- Familial Ovarian Cancer Registry World's largest and oldest registry storing data and biospecimens from families with higher-than-average risk for ovarian cancer, supporting research to discover new genes and prevention methods. Shares de-identified data with the Ovarian Cancer Association Consortium.
- Cancer Coach Program Support program connecting cancer patients with trained cancer coaches to help them navigate their cancer journey from diagnosis through survivorship.
- Elevate Salon Salon providing free services including haircuts, wigs, and head coverings for cancer patients undergoing treatment, supporting patient well-being and confidence.
- Roswell Park Care Network Partnership network of cancer care providers across New York State that expands patient access to Roswell Park quality cancer care in local communities.
- Department of Indigenous Cancer Health Department focused on reducing the cancer burden on Indigenous peoples regionally, nationally, and internationally through culturally-attuned cancer care, community-driven partnerships, collaborative research, and education.
- Survivorship Center Survivorship care program offering survivorship care plans, follow-up monitoring, management of treatment side effects, and preventive care for cancer survivors.
- First Responder Cancer Screening Program Cancer screening program for first responders (firefighters, police) with elevated cancer risks due to occupational exposure, providing baseline low-dose CT scans and occupational health monitoring in partnership with the Buffalo Fire Department.
Quantifiable outcome
- Mammography screening reduces risk of dying from breast cancer by 20 to 40%
- +2 more outcomes
Companies that use Global Biotechnology & Cancer Therapeutics
Customer profileNamed customers5 records
Segments7 records
Ideal customer profiles4 records
Global Biotechnology & Cancer Therapeutics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Global Biotechnology & Cancer Therapeutics partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core, major and minor.
- Indian Health Service (IHS)coreRoswell Park holds a cancer-focused Memorandum of Understanding with Indian Health Service to reduce cancer's impact on Native communities. The partnership supports the Department of Indigenous Cancer Health in addressing cancer health disparities in Indigenous populations regionally, nationally, and internationally.
- Ovarian Cancer Association ConsortiumcoreThe Familial Ovarian Cancer Registry shares de-identified data and biospecimens with the Ovarian Cancer Association Consortium, the largest consortium in the world focused on identifying genetic risks for ovarian cancer. This collaboration extends the registry's research impact internationally.
- Buffalo Fire DepartmentcorePartnership to provide baseline low-dose CT scans for all Buffalo firefighters - a first-of-its-kind initiative nationwide. Approximately 750 firefighters scanned through the program. Rose from cancer diagnoses and findings after 9/11 attacks.
- West Herr Automotive GroupmajorPresenting sponsor of the annual Ride for Roswell fundraising event. Partnership powers the flagship fundraising event that raised $6.3 million in 2026.
- Seneca NationcoreIndigenous community partner supporting cancer health outreach, education, and screening initiatives. Roswell Park is situated in homelands of the Haudenosaunee Confederacy with ongoing partnerships with Indigenous Nations.
- Buffalo IVF AssociatesminorFertility specialist partner collaborating with Roswell Park's Young Adult Program for fertility preservation services. Coordinates with oncology teams for patients seeking fertility preservation before cancer treatment.
- University at BuffalocoreHost venue for Ride for Roswell event at University at Buffalo North Campus. Ongoing research and educational collaboration as part of the academic cancer center ecosystem.
Scale indicators12 records
Recent moves6 records
Expansion highlights6 records
Global Biotechnology & Cancer Therapeutics competitors and assessment
Company assessmentDirect peers
- Memorial Sloan Kettering Cancer Center: NCI-designated Comprehensive Cancer Center in New York City offering the same full-spectrum oncology services (medical oncology, surgery, radiation, cellular therapy, clinical trials). Directly comparable in scope and designation, though with substantially larger national brand and patient base.
- Fred Hutchinson Cancer Center: Seattle-based NCI-designated Comprehensive Cancer Center renowned for bone marrow transplantation and immunotherapy research. Direct peer in cellular therapy/transplant and NCI research designation.
- Winship Cancer Institute of Emory University: NCI-designated Comprehensive Cancer Center at Emory in Atlanta, similar scale tier, providing full-spectrum oncology care and clinical trials. Comparable academic comprehensive cancer center.
- Abramson Cancer Center (Penn Medicine): University of Pennsylvania's NCI-designated Comprehensive Cancer Center with strength in cellular therapy, immunotherapy, and clinical trials. Comparable academic NCI comprehensive peer in the Northeast.
- Dana-Farber Cancer Institute: Harvard-affiliated NCI-designated Comprehensive Cancer Center in Boston with deep translational research portfolio and full clinical service lines. Comparable as an academic NCI comprehensive center focused on oncology specialization and clinical trials.
- Moffitt Cancer Center: NCI-designated Comprehensive Cancer Center in Tampa, Florida, with similar scale, research intensity, and full-spectrum oncology services including cellular therapy. Closest peer by bed count and revenue tier among Florida/Southeast academic cancer centers.
- MD Anderson Cancer Center: Largest NCI-designated Comprehensive Cancer Center, providing full-spectrum oncology care, research, and clinical trials. Comparable in NCI designation, research intensity, and cellular therapy leadership, but with much larger geographic reach and brand recognition.
- University of Chicago Medicine Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center with deep translational research and a long-standing ovarian cancer SPORE partnership with Roswell Park. Directly comparable on gynecologic oncology research and NCI designation.
Regional players
- Herbert Irving Comprehensive Cancer Center (Columbia/NYP): NCI-designated Comprehensive Cancer Center at Columbia University in NYC. Comparable in research intensity and NCI designation but serving primarily the downstate NY patient base rather than directly competing in Roswell Park's Western NY territory.
- Perlmutter Cancer Center (NYU Langone): NCI-designated Comprehensive Cancer Center in New York City, overlapping with Roswell Park's New York State footprint as a competitor for in-region referrals but primarily serving the NYC metro catchment rather than Western NY.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Global Biotechnology & Cancer Therapeutics social profiles
Digital presenceGlobal Biotechnology & Cancer Therapeutics compliance and trust
Trust signalCompliance5 records
Global Biotechnology & Cancer Therapeutics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Global Biotechnology & Cancer Therapeutics leadership team
Management profileNumber of profiles
Profiles9 records
Global Biotechnology & Cancer Therapeutics subsidiaries and ownership
Company hierarchySubsidiaries1 record
Global Biotechnology & Cancer Therapeutics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Global Biotechnology & Cancer Therapeutics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Global Biotechnology & Cancer Therapeutics
What does Global Biotechnology & Cancer Therapeutics do?
Global Biotechnology & Cancer Therapeutics delivers comprehensive cancer care spanning prevention, screening, diagnosis, treatment, and survivorship, including surgery, radiation therapy, chemotherapy, immunotherapy, cellular therapy, and HIPEC. It operates a mobile cancer screening program (EDDY), runs clinical trials, and maintains the world's largest Familial Ovarian Cancer Registry, serving patients and referring physicians across Western New York, New York State, and the broader Northeast U.S.
Is Global Biotechnology & Cancer Therapeutics a public or private company?
Global Biotechnology & Cancer Therapeutics is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Global Biotechnology & Cancer Therapeutics founded?
Global Biotechnology & Cancer Therapeutics was founded in 1898. It employs 1,001 to 5,000 people.
Where is Global Biotechnology & Cancer Therapeutics based?
Global Biotechnology & Cancer Therapeutics is headquartered in Buffalo, United States, in the North America region.
How does Global Biotechnology & Cancer Therapeutics make money?
Four revenue lines are on record. Patient Care Services are the primary driver. The others are clinical Trials, donations and Fundraising and cancer Screening Services.
Who are Global Biotechnology & Cancer Therapeutics's main competitors?
Direct peers on record are Memorial Sloan Kettering Cancer Center, Fred Hutchinson Cancer Center, Winship Cancer Institute of Emory University, Abramson Cancer Center (Penn Medicine), Dana-Farber Cancer Institute, Moffitt Cancer Center, MD Anderson Cancer Center and University of Chicago Medicine Comprehensive Cancer Center. Regional players are Herbert Irving Comprehensive Cancer Center (Columbia/NYP) and Perlmutter Cancer Center (NYU Langone).
Does Global Biotechnology & Cancer Therapeutics have an API?
No public API is recorded for Global Biotechnology & Cancer Therapeutics.
What industry is Global Biotechnology & Cancer Therapeutics in?
Global Biotechnology & Cancer Therapeutics's product category is Cancer Treatment & Oncology Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAKAFAF, Gynecologic Oncology. Its NAICS code is 622310 and its SIC code is 8060.